ACT + Exercise + Social Support for Women with HIV
(WE RISE Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It focuses on improving medication adherence, so it's likely you will continue your current HIV treatment.
Research suggests that Acceptance and Commitment Therapy (ACT) can help improve physical activity and engagement in HIV care, which are important for managing HIV. Additionally, ACT has shown promise in improving resilience and quality of life in other conditions, indicating its potential benefits for women with HIV.
12345The research suggests that therapeutic exercise and social support are generally safe for people with HIV, as they can help with mental health issues like depression and improve adherence to treatment. However, the specific combination of ACT, exercise, and social support has not been directly studied for safety, but each component individually is considered safe.
678910This treatment is unique because it combines Acceptance and Commitment Therapy (ACT), which helps individuals accept their thoughts and feelings while committing to positive behavior changes, with physical exercise and empathetic social support. This holistic approach addresses both mental and physical health, aiming to improve overall well-being and engagement in HIV care, which is not typically the focus of standard HIV treatments.
211121314Eligibility Criteria
This trial is for women living with HIV who struggle with substance use, have experienced trauma, and may have difficulty sticking to their medication regimen. Participants should be connected to community organizations in the four target counties.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo the WE RISE intervention, which includes acceptance and commitment therapy, exercise, and social support, delivered twice a week for 8 weeks.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at weeks 0, 8, 24, and 48.
Observational
Observational study focusing on the sustainability of the WE RISE intervention, with the same assessment schedule as in phase 1.